NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

降脂藥的全球市場分析 (2021年):新型冠狀病毒感染疾病 (COVID-19)的影響與復甦過程 (2030年)

Hypolipidemics Global Market Report 2021: COVID-19 Impact And Recovery To 2030

出版商 The Business Research Company 商品編碼 1014876
出版日期 按訂單生產 內容資訊 英文 175 Pages
商品交期: 2-10個工作天內
價格
降脂藥的全球市場分析 (2021年):新型冠狀病毒感染疾病 (COVID-19)的影響與復甦過程 (2030年) Hypolipidemics Global Market Report 2021: COVID-19 Impact And Recovery To 2030
出版日期: 按訂單生產內容資訊: 英文 175 Pages
簡介

本報告提供全球降脂藥的市場結構·趨勢相關分析,提供市場的主要特徵·結構,及整體市場規模·成長率趨勢預測,各市場區隔 (各產品種類·各用途) 及地區別·主要國家詳細趨勢,主要企業的簡介,近幾年的主要趨勢,今後的市場機會等調查。

目錄

第1章 摘要整理

第2章 降脂藥市場特徵

第3章 降脂藥市場趨勢與策略

第4章 新型冠狀病毒感染疾病 (COVID-19)對降脂藥市場的影響

第5章 降脂藥市場:市場規模·成長率

  • 市場規模 (以金額為準,2015年∼2020年)
    • 推動市場要素
    • 阻礙市場要素
  • 市場規模 (以金額為準,2020年∼2025年,2030年)
    • 推動市場要素
    • 阻礙市場要素

第6章 降脂藥市場:各領域分析

  • 各產品種類的市場規模 (以金額為準,2015年∼2020年/2020年∼2025年/2030年)
  • 膽酸調整劑
  • HMG-CoA還原酶抑制劑
  • 腺苷酸環化酶抑製劑
  • 菸酸類藥物
  • 其他
  • 各用途的市場規模 (以金額為準,2015年∼2020年/2020年∼2025年/2030年)
  • 醫院
  • 診所
  • 藥局
  • 心血管科

第7章 降脂藥市場:各地區·各國分析

  • 各地區的市場規模 (以金額為準,2015年∼2020年/2020年∼2025年/2030年)
  • 各國市場規模 (以金額為準,2015年∼2020年/2020年∼2025年/2030年)

第8章 亞太地區的降脂藥市場

  • 市場概要
  • 地區資訊
  • 各產品種類的市場規模 (以金額為準,2015年∼2020年/2020年∼2025年/2030年)
  • 各用途的市場規模 (以金額為準,2015年∼2020年/2020年∼2025年/2030年)

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐的降脂藥市場

第16章 英國市場

第17章 德國市場

第18章 法國市場

第19章 東歐的降脂藥市場

第20章 俄羅斯市場

第21章 北美的降脂藥市場

第22章 美國市場

第23章 南美的降脂藥市場

第24章 巴西市場

第25章 中東的降脂藥市場

第26章 非洲的降脂藥市場

第27章 降脂藥市場:競爭情形和企業簡介

  • 競爭情形
  • 企業簡介
    • ABBOTT LABORATORIES LIMITED
    • Apotex Fermentation Inc.
    • BIOCON LIMITED IN Bangalore
    • Cadila Healthcare Limited
    • Chunghwa Chem Syn& Biotech Co., Ltd

第28章 降脂藥的開發平台分析

第29章 降脂藥市場上主要企業合併·收購 (M&A)

第30章 降脂藥市場:未來展望與潛在力分析

第31章 附錄

目錄

Hypolipidemics Global Market Report 2021: COVID-19 Impact and Recovery to 2030 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global hypolipidemics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the hypolipidemics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Hypolipidemics Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Product Type: Cholic Acid Regulator; HMG-CoA Reductase Inhibitors; Adenylate Cyclase Inhibitors; Nicotinic Acid Drugs; Others

2) By Application: Hospital; Clinics; Pharmacy; Cardiovasology

Companies Mentioned: ABBOTT LABORATORIES LIMITED; Apotex Fermentation Inc.; BIOCON LIMITED; Cadila Healthcare Limited; Chunghwa Chem Syn& Biotech

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Hypolipidemic Drugs Market Characteristics

3. Hypolipidemic Drugs Market Trends And Strategies

4. Impact Of COVID-19 On Hypolipidemic Drugs

5. Hypolipidemic Drugs Market Size And Growth

  • 5.1. Global Hypolipidemic Drugs Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Hypolipidemic Drugs Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Hypolipidemic Drugs Market Segmentation

  • 6.1. Global Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Cholic Acid Regulator
  • HMG-CoA Reductase Inhibitors
  • Adenylate Cyclase Inhibitors
  • Nicotinic Acid Drugs
  • Others
  • 6.2. Global Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital
  • Clinics
  • Pharmacy
  • Cardiovasology

7. Hypolipidemic Drugs Market Regional And Country Analysis

  • 7.1. Global Hypolipidemic Drugs Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Hypolipidemic Drugs Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Hypolipidemic Drugs Market

  • 8.1. Asia-Pacific Hypolipidemic Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Hypolipidemic Drugs Market

  • 9.1. China Hypolipidemic Drugs Market Overview
  • 9.2. China Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Hypolipidemic Drugs Market

  • 10.1. India Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Hypolipidemic Drugs Market

  • 11.1. Japan Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Hypolipidemic Drugs Market

  • 12.1. Australia Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Hypolipidemic Drugs Market

  • 13.1. Indonesia Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Hypolipidemic Drugs Market

  • 14.1. South Korea Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Hypolipidemic Drugs Market

  • 15.1. Western Europe Hypolipidemic Drugs Market Overview
  • 15.2. Western Europe Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Hypolipidemic Drugs Market

  • 16.1. UK Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Hypolipidemic Drugs Market

  • 17.1. Germany Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Hypolipidemic Drugs Market

  • 18.4. France Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Hypolipidemic Drugs Market

  • 19.1. Eastern Europe Hypolipidemic Drugs Market Overview
  • 19.2. Eastern Europe Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Hypolipidemic Drugs Market

  • 20.1. Russia Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Hypolipidemic Drugs Market

  • 21.1. North America Hypolipidemic Drugs Market Overview
  • 21.2. North America Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Hypolipidemic Drugs Market

  • 22.1. USA Hypolipidemic Drugs Market Overview
  • 22.2. USA Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Hypolipidemic Drugs Market

  • 23.1. South America Hypolipidemic Drugs Market Overview
  • 23.2. South America Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Hypolipidemic Drugs Market

  • 24.1. Brazil Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Hypolipidemic Drugs Market

  • 25.1. Middle East Hypolipidemic Drugs Market Overview
  • 25.2. Middle East Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Hypolipidemic Drugs Market

  • 26.1. Africa Hypolipidemic Drugs Market Overview
  • 26.2. Africa Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Hypolipidemic Drugs Market Competitive Landscape And Company Profiles

  • 27.1. Hypolipidemic Drugs Market Competitive Landscape
  • 27.2. Hypolipidemic Drugs Market Company Profiles
    • 27.2.1. ABBOTT LABORATORIES LIMITED
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Apotex Fermentation Inc.
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. BIOCON LIMITED IN Bangalore
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Cadila Healthcare Limited
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Chunghwa Chem Syn& Biotech Co., Ltd
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Hypolipidemic Drugs Pipeline Analysis

29. Key Mergers And Acquisitions In The Hypolipidemic Drugs Market

30. Hypolipidemic Drugs Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer